QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 291 filers reported holding QIAGEN NV in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $112 | -8.2% | 2,757 | +1.9% | 0.00% | 0.0% |
Q2 2023 | $122 | +60.5% | 2,705 | +63.4% | 0.00% | 0.0% |
Q1 2023 | $76 | +72.7% | 1,655 | +88.1% | 0.00% | – |
Q4 2022 | $44 | -99.9% | 880 | +1.6% | 0.00% | – |
Q3 2022 | $36,000 | +260.0% | 866 | +314.4% | 0.00% | – |
Q2 2022 | $10,000 | -64.3% | 209 | -63.9% | 0.00% | – |
Q1 2022 | $28,000 | +366.7% | 579 | +446.2% | 0.00% | – |
Q4 2021 | $6,000 | +200.0% | 106 | +221.2% | 0.00% | – |
Q2 2021 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q2 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | +100.0% | 33 | +65.0% | 0.00% | – |
Q4 2018 | $1,000 | -66.7% | 20 | -75.0% | 0.00% | – |
Q3 2018 | $3,000 | – | 80 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |